Spotlight
Clinical Role
Clinical
Supplement Spotlight
CE
Subscribe
Use of PARP Inhibitors in Breast Cancer: Implications for Pharmacy Practice
home / webinars-webcasts / use-of-parp-inhibitors-in-breast-cancer-implications-for-pharmacy-practice
About 1 in 8 women in the United States will develop breast cancer in their lifetime. Overall mortality for breast cancer has decreased over the years with the addition of complex treatment, such as PARP inhibitors. The webcast discusses this class of medications and see how they fit into the treatment paradigm for breast cancer.
EP. 1: Use of PARP Inhibitors in Breast Cancer: Implications for Pharmacy Practice
September 9th 2022About 1 in 8 women in the United States will develop breast cancer in their lifetime. Overall mortality for breast cancer has decreased over the years with the addition of complex treatment, such as PARP inhibitors. The webcast discusses this class of medications and see how they fit into the treatment paradigm for breast cancer.
Watch
